CRISM Therapeutics Corporation (AIM:CRTX)
10.75
-0.25 (-2.28%)
Jul 29, 2025, 4:35 PM GMT+1
CRISM Therapeutics Employees
CRISM Therapeutics had 4 employees as of December 31, 2023. The number of employees decreased by 12 or -75.00% compared to the previous year.
Employees
4
Change (1Y)
-12
Growth (1Y)
-75.00%
Revenue / Employee
6.25K GBP
Profits / Employee
-151.75K GBP
Market Cap
4.30M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4 | -12 | -75.00% |
Dec 31, 2022 | 16 | -16 | -50.00% |
Dec 31, 2021 | 32 | 0 | - |
Dec 31, 2020 | 32 | -31 | -49.21% |
Dec 31, 2018 | 63 | 1 | 1.61% |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,382 |
CRISM Therapeutics News
- 4 weeks ago - AIM Market Roundup: Mobile Tornado, Mediazest, Pri0r1ty Intelligence - The Armchair Trader
- 3 months ago - AIM Market Roundup: Surface Transforms, AFC Energy, Empyrean Energy - The Armchair Trader